• 1. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 5. Etching of glass microchips with supercritical water?
  Pavel Karásek,Jakub Grym,Michal Roth,Josef Planeta,Franti?ek Foret Lab Chip, 2015,15, 311-318

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Introduction to 2-(4-bromo-5-methylthiophen-2-yl)-2-oxoacetic acid (CAS No. 569688-54-6)

2-(4-bromo-5-methylthiophen-2-yl)-2-oxoacetic acid, identified by its Chemical Abstracts Service (CAS) number 569688-54-6, is a significant compound in the realm of pharmaceutical chemistry and medicinal research. This heterocyclic derivative features a thiophene core substituted with bromine and methyl groups, coupled with an acetoacetate moiety, making it a versatile scaffold for drug discovery and synthetic applications.

The structural configuration of 2-(4-bromo-5-methylthiophen-2-yl)-2-oxoacetic acid positions it as a valuable intermediate in the synthesis of biologically active molecules. The presence of the bromo and methyl substituents on the thiophene ring enhances its reactivity, allowing for further functionalization through cross-coupling reactions, nucleophilic substitutions, and other organic transformations. These properties make it particularly useful in the development of novel therapeutic agents targeting various diseases.

In recent years, there has been growing interest in thiophene-based compounds due to their broad spectrum of biological activities. Research has demonstrated that derivatives of thiophene can exhibit antimicrobial, anti-inflammatory, anticancer, and neuroprotective properties. The acetoacetate group in 2-(4-bromo-5-methylthiophen-2-yl)-2-oxoacetic acid further contributes to its pharmacological potential by serving as a precursor for β-keto esters, which are known to be pharmacologically active.

One of the most compelling aspects of 2-(4-bromo-5-methylthiophen-2-yl)-2-oxoacetic acid is its role in the synthesis of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways, and their dysregulation is associated with numerous diseases, including cancer. By leveraging the reactivity of the bromo and methyl groups, researchers have been able to develop novel kinase inhibitors that target specific pathways involved in disease progression. For instance, studies have shown that thiophene derivatives can inhibit tyrosine kinases, which are overactive in certain types of cancer.

The acetoacetate moiety in 2-(4-bromo-5-methylthiophen-2-yl)-2-oxoacetic acid also makes it a valuable building block for the synthesis of chiral compounds. Chirality is a fundamental aspect of many drugs, as enantiomers can exhibit different biological activities. By incorporating chiral auxiliaries or catalysts during the synthesis process, researchers can produce enantiomerically pure forms of this compound, which could lead to more effective and targeted therapies.

Recent advancements in computational chemistry have further enhanced the utility of 2-(4-bromo-5-methylthiophen-2-yl)-2-oxoacetic acid. Molecular modeling studies have helped researchers predict the binding affinities and interactions between this compound and its biological targets. These insights have been instrumental in optimizing drug candidates for better efficacy and reduced side effects. Additionally, virtual screening techniques have been employed to identify new derivatives with enhanced pharmacological properties.

The pharmaceutical industry has also been exploring the use of 2-(4-bromo-5-methylthiophen-2-yl)-2-oxoacetic acid in the development of personalized medicine approaches. By understanding individual genetic variations, researchers can tailor drug designs to match specific patient profiles. This approach holds promise for treating complex diseases such as Alzheimer's and Parkinson's by targeting unique molecular pathways.

In conclusion, 2-(4-bromo-5-methylthiophen-2-yl)-2-oxoacetic acid (CAS No. 569688-54-6) is a multifaceted compound with significant potential in pharmaceutical research and drug development. Its unique structural features, coupled with recent advancements in synthetic and computational chemistry, make it a cornerstone in the quest for novel therapeutic agents. As research continues to uncover new applications for this compound, its importance in medicinal chemistry is likely to grow even further.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)